EarlySense today said it has sold its contact-free continuous monitoring technology to Hillrom. Through the deal, EarlySense will receive licensing for all intellectual property and technology sold to Hillrom and $30 million in cash with potential payments based on certain commercial milestone achievements. EarlySense will also receive a portion of Hillrom’s equity investment in the […]
EarlySense
COVID-19 test development surges with pandemic
Companies around the world are racing to develop and distribute tests for COVID-19 to laboratories and to market other products and services they say can help patients and healthcare providers cope with the pandemic. On March 13, the FDA gave Thermo Fisher Scientific (NYSE:TMO) emergency use authorization (EUA) for a diagnostic test that certain U.S. laboratories […]
DaVita taps Javier Rodriguez as CEO | Personnel Moves – April 29, 2019
DaVita Healthcare (NYSE:DVA) said today that its board of directors unanimously elected Javier Rodriguez to succeed Kent Thiry as its new CEO, effective June 1. The Denver-based company said that former CEO Thiry will transition to serve as executive chairman of the board, and that the announcement comes as part of a multi-year succession planning process. […]
Hill-Rom gets in on $39m round for EarlySense
Hill-Rom (NYSE:HRC) and Wells Fargo Strategic Capital (NYSE:WFC) led a $39 million funding round for EarlySense and its contact-free patient monitoring technology, the Israeli company said today. Other participants in the round included BlueRed Capital, the Israel Innovation Fund, Argos Capital and Hotung Capital and existing investors Pitango Venture Capital and JK&B Venture Capital. “Millions of beds worldwide require […]
Neuros Medical taps ex-Sequent CEO Wilder for corner office | Personnel Moves, August 28, 2017
Neuros Medical said it named Tom Wilder, the CEO who led Sequent Medical to a $280 million acquisition by Terumo Corp. (TYO:4543), to take the corner office. “Neuros Medical, with its patented Altius system high-frequency nerve block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result […]
7 medtech stories we missed this week: Aug. 25, 2017
From InspireMD’s Swiss distribution deal to CoreLink’s stackable guide wire launch, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD announces Swiss distribution deal InspireMD announced in an Aug. 25 press release that it has signed an agreement with 1a Medical to distribute the CGuard EPS […]
7 medtech stories we missed this week: May 26, 2017
From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. […]
VCs put more into medtech last year | Medtech funding for the week of January 19, 2015
Press Release: EarlySense chair sensor receives FDA clearance
EarlySense touts FDA win for novel chair-based vital sign sensor
Monitoring systems maker EarlySense this week touted FDA clearance for its 1st-of-a-kind Chair Sensor Solution, a continuous vital sign monitor based in a chair.
The contact-free system monitors heart rate, respiratory rate and movement in patients seated upright, a position that EarlySense says improves healing, reduces the risk of complications and shortens length of stay for patients in the hospital.
Welch Allyn debuts monitor with tech from Masimo, Covidien, EarlySense
